• Neurocrine Biosciences average return on investment for 2023 was 35.19, a 400.57% increase from 2022.
• Neurocrine Biosciences average return on investment for 2022 was 7.03, a 76.54% increase from 2021.
• Neurocrine Biosciences average return on investment for 2021 was 29.97, a 25.04% decline from 2020.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.